EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design, Synthesis, and Antibacterial Evaluation of Rifampicin–Siderophore Conjugates

Vladyslav Lysenko iD, Mei-Ling Gao, Fabienne A C Sterk iD, Paolo Innocenti, Cornelis J Slingerland iD, Nathaniel I Martin iD

ACS Infectious Diseases · 08.08.2025 · 11 (8) · 2301-2309

DOI: 10.1021/acsinfecdis.5c00311 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 05.07.2025. Verfasst von Vladyslav Lysenko und 5 weiteren Autor:innen. Beteiligte Einrichtung: Biological Chemistry Group, Institute of Biology Leiden, Leiden University, Sylviusweg 72, 2333 BE Leiden, The Netherlands. Hauptthemen laut MEDLINE: Rifampin, Anti-Bacterial Agents, Siderophores, Gram-Negative Bacteria. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Scholarship Council, Nederlandse Organisatie voor Wetenschappelijk Onderzoek.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The growing concern over antibiotic resistance has sparked increased attention toward developing alternative antibiotic strategies. One promising approach, known as the "Trojan horse" strategy, involves the use of siderophores to hijack bacteria's iron transport systems as a way of delivering antibiotics inside the bacterial cell. This method is particularly promising in tackling Gram-negative bacteria, which have an outer membrane that many antibiotics cannot penetrate. One such antibiotic is rifampicin, a drug used to treat tuberculosis and infections caused by Gram-positive bacteria. Although rifampicin binds to a highly conserved bacterial RNA subunit, its activity is generally poor against Gram-negative bacteria due to their outer membrane. Aiming to expand rifampicin's efficacy, we here report the design and synthesis of several rifampicin-siderophore conjugates that exhibit enhanced activity against Gram-negative pathogens. Our findings indicate that the structural features of both the linker and catechol are crucial for the activity of conjugates with compound 33, wherein rifampicin is connected to chlorocatechol via a short ester linker, showing an up to 32-fold improvement in activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RifampinAnti-Bacterial AgentsSiderophoresGram-Negative BacteriaMicrobial Sensitivity TestsDrug Design

Stichwörter der Autor:innen

Gram-negative bacteriaTrojan horseantibioticconjugateresistancerifampicinsiderophore

Substanzen

RifampinAnti-Bacterial AgentsSiderophores

Autor:innen und Institutionen

  • Biological Chemistry Group, Institute of Biology Leiden, Leiden University, Sylviusweg 72, 2333 BE Leiden, The Netherlands.

ORCID-Profile: Vladyslav Lysenko, Fabienne A C Sterk, Cornelis J Slingerland, Nathaniel I Martin

Förderung

  • China Scholarship Council
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Zitieren

APA

Lysenko, V., Gao, M. L., Sterk, F. A. C., Innocenti, P., Slingerland, C. J., & Martin, N. I. (2025). Design, Synthesis, and Antibacterial Evaluation of Rifampicin–Siderophore Conjugates. ACS Infectious Diseases, 11(8), 2301-2309. https://doi.org/10.1021/acsinfecdis.5c00311

Vancouver

Lysenko V, Gao ML, Sterk FAC, Innocenti P, Slingerland CJ, Martin NI. Design, Synthesis, and Antibacterial Evaluation of Rifampicin–Siderophore Conjugates. ACS Infectious Diseases. 2025;11(8):2301-2309. doi:10.1021/acsinfecdis.5c00311

BibTeX
@article{Lysenko2025,
  author = {Lysenko, Vladyslav and Gao, Mei-Ling and Sterk, Fabienne A C and Innocenti, Paolo and Slingerland, Cornelis J and Martin, Nathaniel I},
  title = {Design, Synthesis, and Antibacterial Evaluation of Rifampicin–Siderophore Conjugates},
  journal = {ACS Infectious Diseases},
  year = {2025},
  volume = {11},
  number = {8},
  pages = {2301--2309},
  doi = {10.1021/acsinfecdis.5c00311}
}
Kostenlos starten →